Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-09-02 19:56:55 ET · period of report 2026-08-31 · accession 0001230724-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 19:56 | 2026-08-31+ | PCVX | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $61.18 | -2,705 | 102.5K | -3% | -$165.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | F | D | 1,273 | $60.74 | 103,903 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2026-09-02 | F | D | 1,432 | $61.58 | 102,471 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |